OPS
MRNA icon

Orion Portfolio Solutions’s Moderna MRNA Stock Holding History

Orion Portfolio Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,661
Closed -$245K – 1882
2024
Q3 		$245K Buy
3,661
+1,443
+65% +$132K ﹤0.01% 1623
2024
Q2 		$263K Buy
+2,218
New +$281K ﹤0.01% 1509
2024
Q1 		– Sell
-2,538
Closed -$293K – 1726
2023
Q4 		$293K Sell
2,538
-1,939
-43% -$163K ﹤0.01% 1411
2023
Q3 		$462K Sell
4,477
-6,392
-59% -$713K 0.01% 1229
2023
Q2 		$1.32M Buy
10,869
+583
+6% +$77.8K 0.01% 830
2023
Q1 		$1.58M Buy
10,286
+7,120
+225% +$1.17M 0.02% 691
2022
Q4 		$569K Sell
3,166
-2,148
-40% -$351K 0.02% 458
2022
Q3 		$628K Buy
5,314
+3,227
+155% +$490K 0.02% 355
2022
Q2 		$298K Sell
2,087
-31
-1% -$4.43K 0.01% 555
2022
Q1 		$365K Buy
2,118
+598
+39% +$101K 0.01% 521
2021
Q4 		$386K Sell
1,520
-219
-13% -$64K 0.01% 499
2021
Q3 		$669K Buy
1,739
+301
+21% +$111K 0.02% 332
2021
Q2 		$338K Sell
1,438
-458
-24% -$81.8K 0.01% 455
2021
Q1 		$248K Sell
1,896
-362
-16% -$52.5K 0.01% 476
2020
Q4 		$236K Buy
+2,258
New +$228K 0.01% 448
2020
Q3 		– Sell
-955
Closed -$61K – 1436
2020
Q2 		$61K Buy
+955
New +$52.3K ﹤0.01% 663

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Orion Portfolio Solutions's MRNA Position: Q4 2024 in Review

Orion Portfolio Solutions sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,661 shares — an estimated $245K sold.

Orion Portfolio Solutions first reported a position in MRNA in Q2 2020 and held it in 16 quarters. The position peaked at $1.58M in Q1 2023. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Orion Portfolio Solutions reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Orion Portfolio Solutions sold 3,661 Moderna shares in Q4 2024, an estimated $245K.
  • Orion Portfolio Solutions first reported a position in Moderna in Q2 2020 and held it in 16 quarters.
  • Orion Portfolio Solutions's Moderna position peaked at $1.58M in Q1 2023.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Orion Portfolio Solutions's 13F filing for Q4 2024, filed 12 Feb 2025.